ERBB2 and breast cancer: Since abnormal phenylalanine metabolism has been shown to play a critical role in the development of cardiac cellular senescence [50], cardiac cellular senescence induced by abnormal phenylalanine metabolism could be a potential mechanism mediating doxorubicin-induced heart failure in HER2-positive breast cancer patients.